Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Verify J-code separability with the specific payer before billing
Additionally, due to inherent proclivity to hemolytic, thrombotic, and other medically threatening events, G6PD-deficient patients may be limited in treatment options available to them, particularly in the case of COVID-19 infection
2024;5(10):e718
Designs for Health Introduces Akkermansia Pro GLP-1 Probiotic to Advance Metabolic and Microbiome Health Support New probiotic and postbiotic blend targets microbiome health, metabolic balance, and healthy body composition through clinically studied ingredients* PALM COAST, Fla., June 17, 2026 /PRNewswire/ -- Designs for Health, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today announced the launch of Akkermansia Pro GLP-1 Probiotic, a groundbreaking once-daily probiotic and postbiotic formula that combines live Akkermansia muciniphila with the clinically studied BPL1 postbiotic to support the gutmetabolic connection, the body's natural GLP-1 production, and healthy weight management.* As research continues to explore the connection between the gut microbiome and metabolic health, emerging science suggests that specific keystone bacterial strains, those that are foundational to the gut microbiome, may play a vital role in supporting appetite regulation, blood sugar metabolism, gut barrier integrity, and overall metabolic resilience
Julia Moore Vogel, coprincipal investigator of the trial who herself has long Covid, says the remote design of the trial was intentional
